Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14356/3062
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDahal, Ashata-
dc.date.accessioned2026-06-30T05:22:28Z-
dc.date.available2026-06-30T05:22:28Z-
dc.date.issued2025-
dc.identifier.urihttps://hdl.handle.net/20.500.14356/3062-
dc.descriptionApproval NHRCen_US
dc.description.abstractNAen_US
dc.description.sponsorshipOxford University Clinical Research Unit-Vietnamen_US
dc.language.isoen_USen_US
dc.relation.ispartofseries;RES01257-
dc.subjectTuberculosisen_US
dc.subjectTuberculosis vaccineen_US
dc.subjectCase studyen_US
dc.subjectNepalen_US
dc.titleCase study on the acceptance of a new tuberculosis vaccine in the general public of three TB-affected districts of Nepalen_US
dc.typeResearch reporten_US
Appears in Collections:Approval Research Report (NHRC)

Files in This Item:
File Description SizeFormat 
RES01257-DAH-2025.pdfRead Full Research report.156.76 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.